SpringerProtocols: Abstract: Combining Lipidomics and Proteomics of Human Cerebrospinal Fluids

4. Combining Lipidomics and Proteomics of Human Cerebrospinal Fluids

By: Alfred N. Fonteh¹, Rachel D. Fisher²

Abstract

Full Text

Download PDF (170K)

Lipids from dietary sources or from de novo synthesis are transported while bound to proteins to other tissues where they are used for cell membrane synthesis or stored for energy generation. In cell membranes or in plasma, lipids can undergo several modifications that are important in cell function. Several proteins orchestrate the transport, biosynthesis, and modification of lipids. Thus, the intersection of lipids and proteins is important in human metabolic pathways. Recent advances in mass spectrometry and bioinformatics have made it possible to obtain compositional (structural and functional) data of lipid molecular species and proteins in biological samples. This combination of lipidomics and proteomics is advantageous because it allows us to better define biochemical pathways, discover new drug targets, and better understand the pathophysiology of several diseases.

Affiliation(s): (1) Molecular Neurology Program, Huntington Medical Research Institutes, Pasadena, CA, USA
(2) Scripps College, Claremont, CA, USA

Book Title: Lipidomics: Volume 1: Methods and Protocols

Series: Methods in Molecular Biology | Volume: 579 | Pub. Date: Oct-02-2009 | Page Range: 71-86 | DOI: 10.1007/978-1-60761-322-0_4

Subject: Cell Biology

Key Words: Lipidomics - Proteomics - Shotgun sequencing - Mass spectrometry - Liquid chromatography - Isotope dilution - Cerebrospinal fluid

References

Download References

1.	Fonteh, A. N., Harrington0, R. J., Huhmer, A. F., Biringer, R. G., Riggins, J. N., and Harrington, M. G. (2006) Identification of disease markers in human cerebrospinal fluid using lipidomic and proteomic methods. Dis Markers 22(1–2), 247–272.

2.	Albers, J. J. (1978) Effect of human plasma apolipoproteins on the activity of purified lecithin:cholesterol acyltransferase. Scand J Clin Lab Invest Suppl 150, 48–52.

3.	Beffert, U., Danik, M., Krzywkowski, P., Ramassamy, C., Berrada, F., and Poirier, J. (1998) The neurobiology of apolipoproteins and their receptors in the CNS and Alzheimer’s disease. Brain Res Brain Res Rev 27(2), 119–142.

4.	Haffner, S., Applebaum-Bowden, D., Wahl, P. W.et al. (1985) Epidemiological correlates of high density lipoprotein subfractions, apolipoproteins A-I, A-II, and D, and lecithin cholesterol acyltransferase. Effects of smoking, alcohol, and adiposity. Arteriosclerosis 5(2), 169–177.

5.	Bazan, N. G., and Allan, G. (1996) Platelet-activating factor is both a modulator of synaptic function and a mediator of cerebral injury and inflammation. Adv Neurol 71, 475–482.

6.	Brady, H. R., and Serhan, C. N. (1996) Lipoxins: putative braking signals in host defense, inflammation and hypersensitivity. Curr Opin Nephrol Hypertens 5(1), 20–27.

7.	Fonteh,vv A. N., and Harrington, M. G. (2004) Remodeling of arachidonate and other polyunsaturated fatty acids in Alzheimer’s disease. In: Fonteh AN, Wykle RL, editors. Arachidonate Remodeling and Inflammation. Birkhauser Verlag 145–168.

8.	Ford-Hutchinson, A. W. (1990) Leukotriene B₄ in inflammation. Crit Rev Immunol 10(1), 1–12.

9.	Lefkowith, J. B. (1988) Essential fatty acid deficiency inhibits the in vivo generation of leukotriene B₄ and suppresses levels of resident and elicited leukocytes in acute inflammation. J Immunol 140(1), 228–233.

10.	O’Banion, M. K. (1999) COX-2 and Alzheimer’s disease: potential roles in inflammation and neurodegeneration. Expert Opin Investig Drugs 8(10), 1521–1536.

11.	Peroutka, S. J. (2005) Neurogenic inflammation and migraine: implications for the therapeutics. Mol Interv 5(5), 304–311.

12.	Pruzanski, W., and Vadas, P. (1989) Phospholipase A₂ and inflammation. Ann Rheum Dis 48(11), 962–963.

13.	Serhan, C. N. (1996) Inflammation. Signalling the fat controller. Nature 384(6604), 23–24.

14.	Zurier, R. B. (1993) Fatty acids, inflammation and immune responses. Prostaglandins Leukot Essent Fatty Acids 48(1), 57–62.

15.	Axelrod, J. (1995) Phospholipase A₂ and G proteins. Trends Neurosci 18(2), 64–65.

16.	Bazan, N. G., Allan, G., and Rodriguez de Turco, E. B. (1993) Role of phospholipase A₂ and membrane-derived lipid second messengers in membrane function and transcriptional activation of genes: implications in cerebral ischemia and neuronal excitability. Prog Brain Res 96, 247–257.

17.	Bonventre, J. V. (1992) Phospholipase A₂ and signal transduction. J Am Soc Nephrol 3(2), 128–150.

18.	Clark, J. D., Schievella, A. R., Nalefski, E. A., and Lin, L. L. (1995) Cytosolic phospholipase A₂. J Lipid Mediat Cell Signal 12(2–3), 83–117.

19.	Dennis, E. A. (2000) Phospholipase A₂ in eicosanoid generation. Am J Respir Crit Care Med 161(2 Pt 2), S32–S35.

20.	Diez, E., Chilton, F. H., Stroup, G., Mayer, R. J., Winkler, J. D., and Fonteh, A. N. (1994) Fatty acid and phospholipid selectivity of different phospholipase A₂ enzymes studied by using a mammalian membrane as substrate. Biochem J 301(Pt 3), 721–726.

21.	Farooqui, A. A., Antony, P., Ong, W. Y., Horrocks, L. A., and Freysz, L. (2004) Retinoic acid-mediated phospholipase A₂ signaling in the nucleus. Brain Res Brain Res Rev 45(3), 179–195.

22.	Fonteh, A. N., Bass, D. A., Marshall, L. A., Seeds, M., Samet, J. M., and Chilton, F. H. (1994) Evidence that secretory phospholipase A₂ plays a role in arachidonic acid release and eicosanoid biosynthesis by mast cells. J Immunol 152(11), 5438–5446.

23.	Kramer, R. M., Stephenson, D. T., Roberts, E.F., and Clemens, J. A. (1996) Cytosolic phospholipase A₂ (cPLA₂) and lipid mediator release in the brain. J Lipid Mediat Cell Signal 14(1–3), 3–7.

24.	Kudo, I., and Murakami, M. (2002) Phospholipase A₂ enzymes. Prostaglandins Other Lipid Mediat 68–69, 3–58.

25.	Cocco, L., Martelli, A. M., Gilmour, R. S., Rhee, S. G., and Manzoli, F. A. (2001) Nuclear phospholipase C and signaling. Biochim Biophys Acta 1530(1), 1–14.

26.	Cockcroft, S. (2006) The latest phospholipase C, PLCeta, is implicated in neuronal function. Trends Biochem Sci 31(1), 4–7.

27.	Manzoli, L., Billi, A. M., Martelli, A. M., and Cocco, L. (2004) Regulation of nuclear phospholipase C activity. Acta Biochim Pol 51(2), 391–395.

28.	Matsushima, H., Shimohama, S., Kawamata, J., Fujimoto, S., Takenawa, T., and Kimura, J. (1998) Reduction of platelet phospholipase C-delta1 activity in Alzheimer’s disease associated with a specific apolipoprotein E genotype (epsilon3/epsilon3). Int J Mol Med 1(1), 91–93.

29.	Minke, B. (2001) The TRP channel and phospholipase C-mediated signaling. Cell Mol Neurobiol 21(6), 629–643.

30.	Nakahara, M., Shimozawa, M., Nakamura, Y., et al. (2005) A novel phospholipase C, PLC(eta)2, is a neuron-specific isozyme. J Biol Chem 280(32), 29128–29134.

31.	Rhee, S. G. (2001) Regulation of phosphoinositide-specific phospholipase C. Annu Rev Biochem 70, 281–312.

32.	Shimohama, S., Sasaki, Y., Fujimoto, S.et al. (1998) Phospholipase C isozymes in the human brain and their changes in Alzheimer’s disease. Neuroscience 82(4), 999–1007.

33.	Stewart, A. J., Mukherjee, J., Roberts, S. J., Lester, D., and Farquharson, C. (2005) Identification of a novel class of mammalian phosphoinositol-specific phospholipase C enzymes. Int J Mol Med 15(1), 117–121.

34.	Cockcroft, S. (2001) Signalling roles of mammalian phospholipase D1 and D2. Cell Mol Life Sci 58(11), 1674–1687.

35.	Jenkins, G. M., and Frohman, M. A. (2005) Phospholipase D: a lipid centric review. Cell Mol Life Sci 62(19–20), 2305–2316.

36.	Klein, J. (2005) Functions and pathophysiological roles of phospholipase D in the brain. J Neurochem 94(6), 1473–1487.

37.	Xie, Z., Ho, W. T., Spellman, R., Cai, S., and Exton, J. H. (2002) Mechanisms of regulation of phospholipase D1 and D2 by the heterotrimeric G proteins G13 and Gq. J Biol Chem 277(14), 11979–11986.

38.	Balazy, M. (2004) Eicosanomics: targeted lipidomics of eicosanoids in biological systems. Prostaglandins Other Lipid Mediat 73(3–4), 173–180.

39.	Fitzpatrick, F. A., and Murphy, R. C. (1988) Cytochrome P-450 metabolism of arachidonic acid: formation and biological actions of “epoxygenase”-derived eicosanoids. Pharmacol Rev 40(4), 229–241.

40.	Lands, W. E. (1993) Eicosanoids and health. Ann N Y Acad Sci 676, 46–59.

41.	Murphy, R. C. (2001) Free-radical-induced oxidation of arachidonoyl plasmalogen phospholipids: antioxidant mechanism and precursor pathway for bioactive eicosanoids. Chem Res Toxicol 14(5), 463–472.

42.	Serhan, C. N., Lu, Y., Hong, S., and Yang, R. (2007) Mediator lipidomics: search algorithms for eicosanoids, resolvins, and protectins. Methods Enzymol 432, 275–317.

43.	Smith, W. L. (1989) The eicosanoids and their biochemical mechanisms of action. Biochem J 259(2), 315–324.

44.	Bazan, N. G., Squinto, S. P., Braquet, P., Panetta, T., and Marcheselli, V. L. (1991) Platelet-activating factor and polyunsaturated fatty acids in cerebral ischemia or convulsions: intracellular PAF-binding sites and activation of a fos/jun/AP-1 transcriptional signaling system. Lipids 26(12), 1236–1242.

45.	Benveniste, J., Chignard, M., Le Couedic, J. P., and Vargaftig, B. B. (1982) Biosynthesis of platelet-activating factor (PAF-ACETHER). II. Involvement of phospholipase A₂ in the formation of PAF-ACETHER and lyso-PAF-ACETHER from rabbit platelets. Thromb Res 25(5), 375–385.

46.	Snyder, F. (1994) Metabolic processing of PAF. Clin Rev Allergy 12(4), 309–327.

47.	Farooqui, A. A., Litsky, M. L., Farooqui, T., and Horrocks, L. A. (1999) Inhibitors of intracellular phospholipase A₂ activity: their neurochemical effects and therapeutical importance for neurological disorders. Brain Res Bull 49(3), 139–153.

48.	Berenbaum, F. (1995) Phospholipase A₂ inhibitors: a challenge for the future. Rev Rhum Engl Ed 62(6), 409–414.

49.	Glaser, K. B., Lock, Y. W., and Chang, J. Y. (1991) PAF and LTB₄ biosynthesis in the human neutrophil: effects of putative inhibitors of phospholipase A₂ and specific inhibitors of 5- lipoxygenase. Agents Actions 34(1–2), 89–92.

50.	Bligh, E. A., and Dyer, W. T. (1959) A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37, 911–917.

51.	Fonteh, A. N. (1999) Assessment of arachidonic acid distribution into phospholipids of inflammatory cells. Methods Mol Biol 120, 77–89.

52.	Biringer, R. G., Amato, H., Harrington, M. G., Fonteh, A. N., Riggins, J. N., and Huhmer, A. F. (2006) Enhanced sequence coverage of proteins in human cerebrospinal fluid using multiple enzymatic digestion and linear ion trap LC-MS/MS. Brief Funct Genomic Proteomic 5(2), 144–153.

53.	Wolters, D. A., Washburn, M. P., and Yates, III J.R. (2001) An automated multidimensional protein identification technology for shotgun proteomics. Anal Chem 73(23), 5683–5690.

54.	Amanchy, R., Kalume, D. E., and Pandey, A. (2005) Stable isotope labeling with amino acids in cell culture (SILAC) for studying dynamics of protein abundance and posttranslational modifications. Sci STKE 267, l2.

55.	Romijn, E. P., Christis, C., Wieffer, M. et al. (2005) Expression clustering reveals detailed co-expression patterns of functionally related proteins during B cell differentiation: a proteomic study using a combination of one-dimensional gel electrophoresis, LC-MS/MS, and stable isotope labeling by amino acids in cell culture (SILAC). Mol Cell Proteomics 4(9), 1297–1310.

56.	Fonteh, A. N., Biringer, R. G., Huhmer, A. F., Rush, J. D., and Harrington, M. G. (2005) Use of [¹³C],[¹⁵N]-peptide standards to quantify enzymes of the Cyclooxygenase and Lipoxygenase pathways in human cerebrospinal fluids. American Society for Mass Spectrometry: Conference Proceeding *5–6*(http://www.asms.org/asms05pdf/A052054.pdf).

57.	Huhmer, A. F., Biringer, R. G., Amato, H., Fonteh, A. N., and Harrington, M. G. (2006) Protein analysis in human cerebrospinal fluid: Physiological aspects, current progress and future challenges. Dis Markers 22(1–2), 211–234.

58.	Lee, S. H., and Blair, I. A. (2007) Targeted chiral lipidomics analysis by liquid chromatography electron capture atmospheric pressure chemical ionization mass spectrometry (LC-ECAPCI/MS). Methods Enzymol 433, 159–174.

59.	Schwudke, D., Liebisch, G., Herzog, R., Schmitz, G., and Shevchenko, A. (2007) Shotgun lipidomics by tandem mass spectrometry under data-dependent acquisition control. Methods Enzymol 433, 175–191.

Comments (Loading...)

Post comment/View all comments